STERIS’ (TSE:STE – Free Report) – Investment analysts at Atb Cap Markets boosted their Q1 2027 earnings per share (EPS) estimates for shares of STERIS’ in a research report issued on Wednesday, June 11th. Atb Cap Markets analyst W. Syed now anticipates that the company will post earnings of $0.49 per share for the quarter, up from their prior forecast of $0.46. Atb Cap Markets also issued estimates for STERIS’’s FY2027 earnings at $1.04 EPS.
Separately, Raymond James downgraded STERIS’ from a “moderate buy” rating to a “hold” rating in a report on Wednesday, April 9th.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- 3 Best Fintech Stocks for a Portfolio Boost
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- Where Do I Find 52-Week Highs and Lows?
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
